The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
In laymans terms a quick tot up of our investments we have circa £2.8m live an non current investments and cash (not including SGSC). If we add the £4m from the PUT option we have an investment value of around £6.8m.
Our Mcap (at the time of writing ) is circa £4.8m, so still potentially still £2m below our investments alone....
So an SP of 0.04 would be fair value.
Asia, i said a while ago, i personally would like to see us sell £1m of conduit shares to allow for working capital etc and leave the rest in and see where it goes. Our BoD have not been great with investments but when they stick to pre IPO investments we tend to do a lot better. having £3m of share in a Nasdaq stock should be beneficial for sure. If AZD1656 does eventually get commercialised we stand to gain very well from Igraine and Conduit whilst having realised a profit already!
Afreed BigDave. Really think they should leave in as much as possible with Conduit/Murf. If the drug comes off then we will have exposure from Igraine and the investment in Conduit. Plus would stop the BoD investing in more dudds!
No completely wrong matty. They paid £2.35m for the interest in SGSC. then paid £400k for option fee. All told we are in to the investment for £2.75m so if we get £4m back its £1.25m profit on an investment the market had written off
What? Before the drop in CODE which was in the last couple days our Investment value and cash value was £3m (even with the £400k option fee taken from the cash reserves) not including anything to do with SGSC. Our Mcap is £3.1m so there is nothing at all priced in for SGSC.